Cannabis Investing RAMM Pharma Corp. Announces Postponement of Filing of Interim Financial Statements
Cannabis Investing RAMM Pharma Corp. Receives Federal Approval and Registration of XALEX™ 10 (cannabidiol) Oral Solution
Pharmaceutical Investing RAMM Pharma Corp. Provides Details on Operational Activities to Support COVID-19 Medical Response Effort & Corporate Update
Cannabis Investing RAMM Pharma Corp. to Acquire NettaLife, a Leading Developer of Cannabis-Based Products for Pets and Large Animals
